HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vega, G. L. Articles by Grundy, S. M. Search for Related Content PubMed PubMed Citation Articles by Vega, G. L. Articles by Grundy, S. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 26, 115-126, Copyright © 1985 by Lipid Research, Inc.

ARTICLES

Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease

GL Vega, WF Beltz and SM Grundy

The turnover rates of low density lipoprotein-apolipoprotein B (LDL- apoB) were determined in 32 men with coronary heart disease (CHD) and 11 control men with normal plasma lipids. Thirty patients with CHD had normal levels of LDL-cholesterol (LDL-C); of these patients, 9 had hypertriglyceridemia and 21 had normal plasma lipids. Mean concentrations of total cholesterol and LDL-C were similar among the control subjects and CHD patients, although the latter had significantly lower HDL-C. In control subjects, transport rates and fractional catabolic rates (FCR) of LDL-B were 10.6 +/- 0.5 (SEM) mg/kg- day and 0.31 +/- 0.01 pools/day, respectively. In 10 hypertriglyceridemic patients with CHD, transport rates were 21.7 +/- 1.7 mg/kg-day, and FCRs averaged 0.56 +/- 0.06 pools/day; both were significantly higher than normal (P less than 0.05). Six normolipidemic patients also had abnormally high transport rates of LDL-apoB (19.4 +/- 2.8 mg/kg-day) and FCRs (0.51 +/- 0.03 pools/day); again both were higher than normal. The remaining 16 normolipidemic patients with CHD had normal transport rates (9.9 +/- 0.6 mg/kg-day) and FCRs (0.28 +/- 0.01 pools/day). Thus, hypertriglyceridemic patients with CHD and a portion of normolipidemic patients with CHD were characterized by increases in both transport and fractional catabolic rate of LDL-apoB; these abnormalities in LDL metabolism may have contributed to their coronary heart disease. However, the majority of normolipidemic patients with CHD did not show a distinct defect in their LDL metabolism.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Arca, G. L. Vega, and S. M. Grundy Hypercholesterolemia in Postmenopausal Women: Metabolic Defects and Response to Low-Dose Lovastatin JAMA, February 9, 1994; 271(6): 453 - 459. [Abstract] [PDF]

				G. L. Vega and S. M. Grundy Comparison of Lovastatin and Gemfibrozil in Normolipidemic Patients With Hypoalphalipoproteinemia JAMA, December 8, 1989; 262(22): 3148 - 3153. [Abstract] [PDF]

				G. L. Vega and S. M. Grundy Treatment of Primary Moderate Hypercholesterolemia With Lovastatin (Mevinolin) and Colestipol JAMA, January 2, 1987; 257(1): 33 - 38. [Abstract] [PDF]

				G. L. Vega and S. M. Grundy Gemfibrozil Therapy in Primary Hypertriglyceridemia Associated With Coronary Heart Disease: Effects on Metabolism of Low-Density Lipoproteins JAMA, April 26, 1985; 253(16): 2398 - 2403. [Abstract] [PDF]